Tobira Therapeutics
(TBRA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 30,770 | 43,538 | N/A | N/A | 0 |
| Other current assets | 6,211 | 4,747 | 0 | 0 | 0 |
| TOTAL | $39,128 | $53,374 | $N/A | $N/A | $0 |
| Non-Current Assets | |||||
| PPE Net | 108 | 102 | N/A | N/A | 0 |
| Intangibles | 1,823 | 2,002 | 0 | 0 | 0 |
| Other Non-Current Assets | 4,694 | 2,095 | 0 | 0 | 0 |
| TOTAL | $6,625 | $4,199 | $N/A | $N/A | $0 |
| Total Assets | $45,753 | $57,573 | $N/A | $N/A | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,000 | 500 | N/A | N/A | 0 |
| Accounts payable and accrued liabilities | 1,557 | 424 | 0 | 0 | 0 |
| Accrued Expenses | 5,524 | 5,028 | N/A | N/A | 0 |
| Other current liabilities | 19 | 23 | N/A | N/A | 0 |
| TOTAL | $9,100 | $5,975 | $N/A | $N/A | $0 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,452 | 3,906 | N/A | N/A | 0 |
| TOTAL | $2,452 | $3,906 | $N/A | $N/A | $0 |
| Total Liabilities | $11,552 | $9,881 | $N/A | $N/A | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,814 | 2,368 | N/A | N/A | 2,264 |
| Common Shares | 21 | 21 | N/A | N/A | 0 |
| Retained earnings | -144,979 | -130,848 | N/A | N/A | 0 |
| TOTAL | $34,201 | $47,692 | $N/A | $N/A | $0 |
| Total Liabilities And Equity | $45,753 | $57,573 | $0 | $0 | $0 |